-
1
-
-
33745225026
-
AMP-activated protein kinase-development of the energy sensor concept
-
Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase.-.development of the energy sensor concept. J Physiol 2006; 574: 7-15.
-
(2006)
J Physiol
, vol.574
, pp. 7-15
-
-
Hardie, D.G.1
Hawley, S.A.2
Scott, J.W.3
-
2
-
-
20844451123
-
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
-
Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1: 15-25.
-
(2005)
Cell Metab
, vol.1
, pp. 15-25
-
-
Kahn, B.B.1
Alquier, T.2
Carling, D.3
Hardie, D.G.4
-
3
-
-
12144287284
-
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
-
Lizcano JM, Goransson O, Toth R et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004; 23: 833-43.
-
(2004)
EMBO J
, vol.23
, pp. 833-843
-
-
Lizcano, J.M.1
Goransson, O.2
Toth, R.3
-
4
-
-
0037032835
-
The protein kinase complement of the human genome
-
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-34.
-
(2002)
Science
, vol.298
, pp. 1912-1934
-
-
Manning, G.1
Whyte, D.B.2
Martinez, R.3
Hunter, T.4
Sudarsanam, S.5
-
5
-
-
0035871220
-
Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK
-
Lefebvre DL, Bai Y, Shahmolky N et al. Identification and characterization of a novel sucrose-non-fermenting protein kinase/ AMP-activated protein kinase-related protein kinase, SNARK. Biochem J 2001; 355: 297-305.
-
(2001)
Biochem J
, vol.355
, pp. 297-305
-
-
Lefebvre, D.L.1
Bai, Y.2
Shahmolky, N.3
-
6
-
-
20444399500
-
Regulation of SNARK activity in response to cellular stresses
-
Lefebvre DL, Rosen CF. Regulation of SNARK activity in response to cellular stresses. Biochim Biophys Acta 2005; 1724: 71-85.
-
(2005)
Biochim Biophys Acta
, vol.1724
, pp. 71-85
-
-
Lefebvre, D.L.1
Rosen, C.F.2
-
7
-
-
0142027180
-
Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family
-
Suzuki A, Kusakai G, Kishimoto A, Minegichi Y, Ogura T, Esumi H. Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family. Biochem Biophys Res Commun 2003; 311: 156-61.
-
(2003)
Biochem Biophys Res Commun
, vol.311
, pp. 156-161
-
-
Suzuki, A.1
Kusakai, G.2
Kishimoto, A.3
Minegichi, Y.4
Ogura, T.5
Esumi, H.6
-
8
-
-
0036323006
-
Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice
-
Cobb S, Wood T, Tessarollo L et.al. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice. Gastroenterology 2002; 123: 516-30.
-
(2002)
Gastroenterology
, vol.123
, pp. 516-530
-
-
Cobb, S.1
Wood, T.2
Tessarollo, L.3
-
9
-
-
33947653911
-
The metabolic syndrome: A high-risk state for cancer?
-
Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006; 169: 1505-22.
-
(2006)
Am J Pathol
, vol.169
, pp. 1505-1522
-
-
Cowey, S.1
Hardy, R.W.2
-
10
-
-
20444379956
-
Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression
-
Cowey SL, Quast M, Belalcazar LM et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 2005; 103: 2643-53.
-
(2005)
Cancer
, vol.103
, pp. 2643-2653
-
-
Cowey, S.L.1
Quast, M.2
Belalcazar, L.M.3
-
11
-
-
30944443326
-
Influence of obesity on the risk of developing colon cancer
-
Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006; 55: 285-91.
-
(2006)
Gut
, vol.55
, pp. 285-291
-
-
Frezza, E.E.1
Wachtel, M.S.2
Chiriva-Internati, M.3
-
12
-
-
2442497348
-
Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice
-
Hirose Y, Hata K, Kuno T et al. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 2004; 25: 821-5.
-
(2004)
Carcinogenesis
, vol.25
, pp. 821-825
-
-
Hirose, Y.1
Hata, K.2
Kuno, T.3
-
13
-
-
34548684104
-
Improvement of hyperlipidemia by indomethacin in Min mice
-
Niho N, Mutoh M, Komiya M, Ohta T, Sugimura T, Wakabayashi K. Improvement of hyperlipidemia by indomethacin in Min mice. Int J Cancer 2007; 121: 1665-9.
-
(2007)
Int J Cancer
, vol.121
, pp. 1665-1669
-
-
Niho, N.1
Mutoh, M.2
Komiya, M.3
Ohta, T.4
Sugimura, T.5
Wakabayashi, K.6
-
14
-
-
14544306090
-
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice
-
Niho N, Mutoh M, Takahashi M, Tsutsumi K, Sugimura T, Wakabayashi K. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci USA 2005; 102: 2970-4.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 2970-2974
-
-
Niho, N.1
Mutoh, M.2
Takahashi, M.3
Tsutsumi, K.4
Sugimura, T.5
Wakabayashi, K.6
-
15
-
-
0141842617
-
Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands
-
Niho N, Takahashi M, Kitamura T et al. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res 2003; 63: 6090-5.
-
(2003)
Cancer Res
, vol.63
, pp. 6090-6095
-
-
Niho, N.1
Takahashi, M.2
Kitamura, T.3
-
16
-
-
0345099451
-
Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligand
-
Niho N, Takahashi M, Shoji Y et al. Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligand. Cancer Sci 2003; 94: 960-4.
-
(2003)
Cancer Sci
, vol.94
, pp. 960-964
-
-
Niho, N.1
Takahashi, M.2
Shoji, Y.3
-
18
-
-
85032021585
-
Tumours of the intestines
-
In: Turusov VS, Mohr U, eds. 2nd edn. Lyon: International Agency for Research on Cancer
-
Krutovskikh VA, Turusov VS. Tumours of the intestines. In: Turusov VS, Mohr U, eds. Pathology of Tumours in Laboratory Animals, 2nd edn. Lyon: International Agency for Research on Cancer, 1994; 195-211.
-
(1994)
Pathology of Tumours in Laboratory Animals
, pp. 195-211
-
-
Krutovskikh, V.A.1
Turusov, V.S.2
-
19
-
-
0029003648
-
Role of aberrant crypt foci in understanding the pathogenesis of colon cancer
-
Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55-71.
-
(1995)
Cancer Lett
, vol.93
, pp. 55-71
-
-
Bird, R.P.1
-
20
-
-
1942439909
-
Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice
-
Hata K, Yamada Y, Kuno T et al. Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci 2004; 95: 316-20.
-
(2004)
Cancer Sci
, vol.95
, pp. 316-320
-
-
Hata, K.1
Yamada, Y.2
Kuno, T.3
-
21
-
-
14844299317
-
Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis
-
Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol 2005; 20: 173-81.
-
(2005)
J Gastroenterol Hepatol
, vol.20
, pp. 173-181
-
-
Hurlstone, D.P.1
Cross, S.S.2
-
22
-
-
4644286712
-
Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer
-
Nambiar PR, Nakanishi M, Gupta R et al. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res 2004; 64: 6394-401.
-
(2004)
Cancer Res
, vol.64
, pp. 6394-6401
-
-
Nambiar, P.R.1
Nakanishi, M.2
Gupta, R.3
-
23
-
-
28844506365
-
Mutant KRAS in aberrant crypt foci (ACF): Initiation of colorectal cancer?
-
Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 2005; 1756: 83-96.
-
(2005)
Biochim Biophys Acta
, vol.1756
, pp. 83-96
-
-
Pretlow, T.P.1
Pretlow, T.G.2
-
24
-
-
0027936114
-
Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats
-
Takahashi M, Minamoto T, Yamashita N, Kato T, Yazawa K, Esumi H. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett 1994; 83: 177-84.
-
(1994)
Cancer Lett
, vol.83
, pp. 177-184
-
-
Takahashi, M.1
Minamoto, T.2
Yamashita, N.3
Kato, T.4
Yazawa, K.5
Esumi, H.6
-
25
-
-
0028321908
-
Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon
-
Yamashita N, Minamoto T, Onda M, Esumi H. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J Cancer Res 1994; 85: 692-8.
-
(1994)
Jpn J Cancer Res
, vol.85
, pp. 692-698
-
-
Yamashita, N.1
Minamoto, T.2
Onda, M.3
Esumi, H.4
-
26
-
-
29744461120
-
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
-
Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 2006; 27: 162-9.
-
(2006)
Carcinogenesis
, vol.27
, pp. 162-169
-
-
Suzuki, R.1
Kohno, H.2
Sugie, S.3
Nakagama, H.4
Tanaka, T.5
-
27
-
-
0023756967
-
Aberrant crypts: Potential preneoplastic lesions in the murine colon
-
McLellan EA, Bird RP. Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Res 1988; 48: 6187-92.
-
(1988)
Cancer Res
, vol.48
, pp. 6187-6192
-
-
McLellan, E.A.1
Bird, R.P.2
|